tirzepatide glp1 FDA says shortage of GLP-1 is over Tirzepatide 10mg — Dual Receptor

Researchers estimate that if Medicare were to lift the prohibition on coverage of GLP-1s for weight loss alone and institute broad coverage of semaglutide-based products, this could prevent nearly 39,000 cardiovascular events and the program could save over $700 million in net costs over ten years

Here at Real Peptides, we live by that principle

Food and Drug Administration (FDA) is sounding the alarm about the risks of using unapproved GLP-1s

These contraindications apply regardless of autoimmune status

doi:10.1016/j.pneurobio.2010.07.003 121

Once the expiration date has passed, the medication may not work as well and could even be unsafe to use